Different phosphodiesterases (PDEs) regulate distinct phosphoproteomes during cAMP signaling | PNAS
Cyclic Nucleotide Phosphodiesterases: important signaling modulators and therapeutic targets - Ahmad - 2015 - Oral Diseases - Wiley Online Library
Phosphodiesterase Inhibitors: What Are They, How Do They Work, What Are They Used For, and More | Osmosis
Resveratrol Ameliorates Aging-Related Metabolic Phenotypes by Inhibiting cAMP Phosphodiesterases: Cell
CV Pharmacology | Phosphodiesterase Inhibitors
Complex roles of cAMP–PKA–CREB signaling in cancer | Experimental Hematology & Oncology | Full Text
Frontiers | The cAMP Pathway as Therapeutic Target in Autoimmune and Inflammatory Diseases
The cyclic AMP signaling pathway: Exploring targets for successful drug discovery (Review)
Phosphodiesterase - Wikipedia
Re: How and why does caffine effect the pulse rate of a person
Frontiers | Phosphodiesterases and cAMP Pathway in Pituitary Diseases
Cyclic Nucleotide Phosphodiesterases: Molecular Regulation to Clinical Use | Pharmacological Reviews
Phosphodiesterase 9A (PDE9)/cGMP ACTOne Cell Line (CB-81300-101), 1 vial CDXC30011
Role of phosphodiesterases in the pathophysiology of neurodevelopmental disorders | Molecular Psychiatry
IJMS | Free Full-Text | Phosphodiesterase Inhibitors: Could They Be Beneficial for the Treatment of COVID-19?
Pivotal effects of phosphodiesterase inhibitors on myocyte contractility and viability in normal and ischemic hearts | Acta Pharmacologica Sinica
IJMS | Free Full-Text | Therapeutic Implications for PDE2 and cGMP/cAMP Mediated Crosstalk in Cardiovascular Diseases | HTML
Phosphodiesterases Catalyze Hydrolysis of cAMP-bound to Regulatory Subunit of Protein Kinase A and Mediate Signal Termination* - Molecular & Cellular Proteomics
Proposed model of phosphodiesterase (PDE) and protein kinase (PK)... | Download Scientific Diagram
Phosphodiesterases in endocrine physiology and disease in: European Journal of Endocrinology Volume 165 Issue 2 (2011)
PDE-Glo™ Phosphodiesterase Assay
Targeting cAMP Signaling for the Treatment of Inflammatory Diseases of the Skin - JDDonline - Journal of Drugs in Dermatology
CV Pharmacology | Phosphodiesterase Inhibitors
The Role of Cyclic 3'-5' Adenosine Monophosphate (cAMP) in Differentiated and Trans-Differentiated Vascular Smooth Muscle Cells | IntechOpen
